Viral and Clinical Oncology of Head and Neck Cancers
Goon P, Schürmann M, Oppel F, Shao SY, Schleyer S, Pfeiffer CJ, Todt I, Brasch F, Scholtz L-U, Göerner M, Sudhoff H (2022)
Current Oncology Reports.
Zeitschriftenaufsatz
| Veröffentlicht | Englisch
Download
s11912-022-01263-7.pdf
1.29 MB
Autor*in
Goon, PeterUniBi;
Schürmann, Matthias;
Oppel, Felix;
Shao, SenYao;
Schleyer, Simon;
Pfeiffer, Christoph J.;
Todt, IngoUniBi;
Brasch, Frank;
Scholtz, Lars-Uwe;
Göerner, Martin;
Sudhoff, HolgerUniBi
Abstract / Bemerkung
**Purpose of Review**
This study assesses the current state of knowledge of head and neck squamous cell carcinomas (HNSCC), which are malignancies arising from the orifices and adjacent mucosae of the aerodigestive tracts. These contiguous anatomical areas are unique in that 2 important human oncoviruses, Epstein-Barr virus (EBV) and human papillomavirus (HPV), are causally associated with nasopharyngeal and oropharyngeal cancers, respectively. Mortality rates have remained high over the last 4 decades, and insufficient attention paid to the unique viral and clinical oncology of the different subgroups of HNSCC. **Recent Findings**
We have compared and contrasted the 2 double-stranded DNA viruses and the relevant molecular oncogenesis of their respective cancers against other head and neck cancers. Tobacco and alcohol ingestion are also reviewed, as regard the genetic progression/mutation accumulation model of carcinogenesis. The importance of stringent stratification when searching for cancer mutations and biomarkers is discussed. Evidence is presented for a dysplastic/pre-invasive cancerous phase for HPV+ oropharyngeal cancers, and analogous with other HPV+ cancers. This raises the possibility of strategies for cancer screening as early diagnosis will undoubtedly save lives. **Summary**
Staging and prognostication have changed to take into account the distinct biological and prognostic pathways for viral+ and viral− cancers. Diagnosis of pre-cancers and early stage cancers will reduce mortality rates. Multi-modal treatment options for HNSCC are reviewed, especially recent developments with immunotherapies and precision medicine strategies. Knowledge integration of the viral and molecular oncogenic pathways with sound planning, hypothesis generation, and clinical trials will continue to provide therapeutic options in the future.
This study assesses the current state of knowledge of head and neck squamous cell carcinomas (HNSCC), which are malignancies arising from the orifices and adjacent mucosae of the aerodigestive tracts. These contiguous anatomical areas are unique in that 2 important human oncoviruses, Epstein-Barr virus (EBV) and human papillomavirus (HPV), are causally associated with nasopharyngeal and oropharyngeal cancers, respectively. Mortality rates have remained high over the last 4 decades, and insufficient attention paid to the unique viral and clinical oncology of the different subgroups of HNSCC. **Recent Findings**
We have compared and contrasted the 2 double-stranded DNA viruses and the relevant molecular oncogenesis of their respective cancers against other head and neck cancers. Tobacco and alcohol ingestion are also reviewed, as regard the genetic progression/mutation accumulation model of carcinogenesis. The importance of stringent stratification when searching for cancer mutations and biomarkers is discussed. Evidence is presented for a dysplastic/pre-invasive cancerous phase for HPV+ oropharyngeal cancers, and analogous with other HPV+ cancers. This raises the possibility of strategies for cancer screening as early diagnosis will undoubtedly save lives. **Summary**
Staging and prognostication have changed to take into account the distinct biological and prognostic pathways for viral+ and viral− cancers. Diagnosis of pre-cancers and early stage cancers will reduce mortality rates. Multi-modal treatment options for HNSCC are reviewed, especially recent developments with immunotherapies and precision medicine strategies. Knowledge integration of the viral and molecular oncogenic pathways with sound planning, hypothesis generation, and clinical trials will continue to provide therapeutic options in the future.
Erscheinungsjahr
2022
Zeitschriftentitel
Current Oncology Reports
Urheberrecht / Lizenzen
ISSN
1523-3790
eISSN
1534-6269
Finanzierungs-Informationen
Open-Access-Publikationskosten wurden durch die Universität Bielefeld im Rahmen des DEAL-Vertrags gefördert.
Page URI
https://pub.uni-bielefeld.de/record/2962091
Zitieren
Goon P, Schürmann M, Oppel F, et al. Viral and Clinical Oncology of Head and Neck Cancers. Current Oncology Reports. 2022.
Goon, P., Schürmann, M., Oppel, F., Shao, S. Y., Schleyer, S., Pfeiffer, C. J., Todt, I., et al. (2022). Viral and Clinical Oncology of Head and Neck Cancers. Current Oncology Reports. https://doi.org/10.1007/s11912-022-01263-7
Goon, Peter, Schürmann, Matthias, Oppel, Felix, Shao, SenYao, Schleyer, Simon, Pfeiffer, Christoph J., Todt, Ingo, et al. 2022. “Viral and Clinical Oncology of Head and Neck Cancers”. Current Oncology Reports.
Goon, P., Schürmann, M., Oppel, F., Shao, S. Y., Schleyer, S., Pfeiffer, C. J., Todt, I., Brasch, F., Scholtz, L. - U., Göerner, M., et al. (2022). Viral and Clinical Oncology of Head and Neck Cancers. Current Oncology Reports.
Goon, P., et al., 2022. Viral and Clinical Oncology of Head and Neck Cancers. Current Oncology Reports.
P. Goon, et al., “Viral and Clinical Oncology of Head and Neck Cancers”, Current Oncology Reports, 2022.
Goon, P., Schürmann, M., Oppel, F., Shao, S.Y., Schleyer, S., Pfeiffer, C.J., Todt, I., Brasch, F., Scholtz, L.-U., Göerner, M., Sudhoff, H.: Viral and Clinical Oncology of Head and Neck Cancers. Current Oncology Reports. (2022).
Goon, Peter, Schürmann, Matthias, Oppel, Felix, Shao, SenYao, Schleyer, Simon, Pfeiffer, Christoph J., Todt, Ingo, Brasch, Frank, Scholtz, Lars-Uwe, Göerner, Martin, and Sudhoff, Holger. “Viral and Clinical Oncology of Head and Neck Cancers”. Current Oncology Reports (2022).
Alle Dateien verfügbar unter der/den folgenden Lizenz(en):
Creative Commons Namensnennung 4.0 International Public License (CC-BY 4.0):
Volltext(e)
Name
s11912-022-01263-7.pdf
1.29 MB
Access Level
Open Access
Zuletzt Hochgeladen
2023-11-28T07:59:31Z
MD5 Prüfsumme
08a6e14aaf021fc65202af35d44a25c6
Daten bereitgestellt von European Bioinformatics Institute (EBI)
Zitationen in Europe PMC
Daten bereitgestellt von Europe PubMed Central.
References
Daten bereitgestellt von Europe PubMed Central.
Export
Markieren/ Markierung löschen
Markierte Publikationen
Web of Science
Dieser Datensatz im Web of Science®Quellen
PMID: 35347592
PubMed | Europe PMC
Suchen in